Premium
Measuring the impact of systemic sclerosis on oral health‐related quality of life in a UK population
Author(s) -
Abdouh Ismail,
Porter Stephen,
Fedele Stefano,
Elgendy Nadia,
Aboalshamat Khalid,
Babkair Hamzah Ali,
Ni Riordain Richeal
Publication year - 2021
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/jop.13177
Subject(s) - medicine , quality of life (healthcare) , depression (economics) , anxiety , population , cross sectional study , hospital anxiety and depression scale , multiple sclerosis , physical therapy , pathology , immunology , psychiatry , nursing , environmental health , economics , macroeconomics
Background The objective of the present study was to identify the impact of systemic sclerosis (SSc) upon oral health‐related quality of life (OHRQoL) of affected individuals resident in the UK. Methods A total of 100 patients and their partners or carers were invited to complete questionnaires regarding the impact of SSc on quality of life and psychological well‐being using valid and reliable patient‐reported outcome measures (OHIP‐14, MHISS, OIDP, MDAS and HADS). A total of 50 patients with SSc and 18 partners or carers who acted as controls returned the completed questionnaires. Statistical analyses were performed for comparisons of different variables. Results All the mean scores of OHIP‐14 (SSc [16.5 ± 12.4] Vs controls [6.06 ± 7.6, p = 0.001]) and MHISS components were significantly higher in patients than those of control group (SSc [21.26 ± 12] Vs controls [4.8 ± 7.3, p < 0.0001]). Majority of OIDP mean scores were significantly worse in patients compared with controls [SSc (10 ± 8.7) Vs controls (1.72 ± 3.4, p < 0.0001)]. The mean of total MDAS [SSc (11.7 ± 5.3) Vs controls (9.5 ± 4.4)] and HADS scores were higher in patients compared to controls (SSc depression [4.8 ± 3.3] and anxiety [6 ± 4.6] Vs controls [3.7 ± 3.1] [4.7 ± 3.9]). Conclusions Although the present study is limited by the low response rate and its cross‐sectional design, present results highlighted that systemic sclerosis has a negative impact on OHRQoL of the affected individuals; hence, the evaluation of associated psychological impact including anxiety and depression symptoms is needed to better understand, monitor and evaluate the disease comorbidity in patients with SSc.